InvestorsHub Logo
Post# of 177724
Next 10
Followers 7
Posts 758
Boards Moderated 0
Alias Born 10/11/2018

Re: None

Saturday, 11/24/2018 8:48:59 PM

Saturday, November 24, 2018 8:48:59 PM

Post# of 177724
Good read yahoo board Terry
The animal medical business is currently a $22 billion dollar business. (People love there animals) It is projected to grow by 5.7% which is a faster growth rate than for human medicine! Normal radiation therapy for animals is a much longer drawn out process. So this could be a real breakthrough for a quicker and less drawn out process which could lead to a lot more people opting to have this treatment for their beloved animals. There are several players in the animal medical market with Pfizer being the largest. This also is a product, as we all know, that has potential for not only animals but for humans also, unlike other animal medical products! So this has to add to the attraction of companies like Pfizer and others that are heavy players in both market places. So even though we don't know whether one of these firms will actually try to buyout or partner with Vivos I'm sure they have there people closely watching! That's there job looking for the next company that has the potential to bring in substantial revenue to the parent firm!
We all know animal studies lead to potential human use. So there is a lot of positives with this stock that could lead to some substantial upside growth! It only takes one player to step up and decide they have seen enough positive testing results on animals alone to make it worth their wild to make a move. At that time some of you will be saying woulda, shoulda, coulda!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News